Brevicon (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Brevicon drug offered from Actavis Pharma, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Norethindrone and ethinyl estradiol |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1976-03-29 |
END MARKETING DATE: | 2018-06-30 |
Brevicon HUMAN PRESCRIPTION DRUG Details:
Item Description | Brevicon from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 1976-03-29 |
END MARKETING DATE: | 2018-06-30 |
PRODUCT ID: | 52544-254_3730181f-3bea-4f88-8760-935ed87acc52 |
PRODUCT NDC: | 52544-254 |
APPLICATION NUMBER: | NDA017743 |